[go: up one dir, main page]

DK3201317T3 - Biomarkører for rheumatoid arthritis og anvendelse deraf - Google Patents

Biomarkører for rheumatoid arthritis og anvendelse deraf Download PDF

Info

Publication number
DK3201317T3
DK3201317T3 DK15847187.0T DK15847187T DK3201317T3 DK 3201317 T3 DK3201317 T3 DK 3201317T3 DK 15847187 T DK15847187 T DK 15847187T DK 3201317 T3 DK3201317 T3 DK 3201317T3
Authority
DK
Denmark
Prior art keywords
biomarketors
rheumatoid arthritis
rheumatoid
arthritis
Prior art date
Application number
DK15847187.0T
Other languages
English (en)
Inventor
Qiang Feng
Dongya Zhang
Huijue Jia
Donghui Wang
Jun Wang
Original Assignee
Bgi Shenzhen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/CN2014/088060 external-priority patent/WO2016049930A1/en
Priority claimed from PCT/CN2014/088069 external-priority patent/WO2016049937A1/en
Priority claimed from PCT/CN2014/088068 external-priority patent/WO2016049936A1/en
Application filed by Bgi Shenzhen filed Critical Bgi Shenzhen
Application granted granted Critical
Publication of DK3201317T3 publication Critical patent/DK3201317T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/335Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Lactobacillus (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Botany (AREA)
DK15847187.0T 2014-09-30 2015-07-07 Biomarkører for rheumatoid arthritis og anvendelse deraf DK3201317T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/CN2014/088060 WO2016049930A1 (en) 2014-09-30 2014-09-30 Biomarkers for rheumatoid arthritis and usage therof
PCT/CN2014/088069 WO2016049937A1 (en) 2014-09-30 2014-09-30 Biomarkers for rheumatoid arthritis and usage therof
PCT/CN2014/088068 WO2016049936A1 (en) 2014-09-30 2014-09-30 Biomarkers for rheumatoid arthritis and usage therof
PCT/CN2015/083488 WO2016050110A1 (en) 2014-09-30 2015-07-07 Biomarkers for rheumatoid arthritis and usage thereof

Publications (1)

Publication Number Publication Date
DK3201317T3 true DK3201317T3 (da) 2020-01-20

Family

ID=55629412

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15847187.0T DK3201317T3 (da) 2014-09-30 2015-07-07 Biomarkører for rheumatoid arthritis og anvendelse deraf

Country Status (11)

Country Link
US (1) US10883146B2 (da)
EP (1) EP3201317B1 (da)
JP (1) JP6485843B2 (da)
KR (1) KR101986442B1 (da)
CN (2) CN108064272B (da)
AU (1) AU2015327511B2 (da)
CA (1) CA2963013C (da)
DK (1) DK3201317T3 (da)
HK (2) HK1248764A1 (da)
RU (1) RU2691375C2 (da)
WO (2) WO2016050111A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11514289B1 (en) 2016-03-09 2022-11-29 Freenome Holdings, Inc. Generating machine learning models using genetic data
WO2019071516A1 (en) * 2017-10-12 2019-04-18 Perfect (China) Co., Ltd. BIOMARKERS FOR CHRONIC HEPATITIS B AND THEIR USE
CN108034708B (zh) * 2017-12-14 2020-05-22 中国中医科学院中药研究所 通过多个mRNA的表达量确定雷公藤多苷片治疗类风湿性关节炎的个体有效性的系统
CN109065168B (zh) * 2018-08-29 2021-09-14 昆明理工大学 一种基于时空聚类统计进行疾病风险评估的方法
CN111161794B (zh) * 2018-12-30 2024-03-22 深圳碳云智能数字生命健康管理有限公司 肠道微生物测序数据处理方法、装置、存储介质及处理器
CN111161795A (zh) * 2019-01-15 2020-05-15 深圳碳云智能数字生命健康管理有限公司 肠道微生物测序数据处理方法、装置、存储介质及处理器
JP2021010343A (ja) * 2019-07-08 2021-02-04 三菱ケミカル株式会社 口腔内細菌による健康状態の予測方法
CN113488107B (zh) * 2021-07-07 2022-07-19 广州华银康医疗集团股份有限公司 筛选免疫组库测序生物标志物的方法、设备和存储介质
CN114369671A (zh) * 2021-11-25 2022-04-19 上海锐翌生物科技有限公司 风湿性关节炎标志微生物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20030274A1 (es) * 2001-07-26 2003-05-08 Alimentary Health Ltd Cepas de lactobacillus salivarius
RU2362808C1 (ru) * 2008-02-13 2009-07-27 Государственное образовательное учреждение дополнительного профессионального образования Российская медицинская академия последипломного образования Федерального агентства по здравоохранению и социальному развитию (ГОУ ДПО РМАПО Росздрава) Способ диагностики дисбаланса микробиоты различных биотопов человека и степени его выраженности
CN101886132B (zh) * 2009-07-15 2013-09-18 北京百迈客生物科技有限公司 基于测序和bsa技术的性状相关的分子标记筛选方法
CN101921748B (zh) * 2010-06-30 2012-11-14 上海华大基因科技有限公司 用于高通量检测人类乳头瘤病毒的dna分子标签
KR20140089384A (ko) * 2011-11-10 2014-07-14 제넨테크, 인크. 알츠하이머병의 치료, 진단 및 모니터링 방법
JP5863035B2 (ja) 2012-03-07 2016-02-16 国立大学法人 東京大学 炎症性腸疾患の検出方法及びヒト唾液細菌叢の検査方法
WO2014019180A1 (zh) * 2012-08-01 2014-02-06 深圳华大基因研究院 确定异常状态生物标记物的方法及系统
US20150211053A1 (en) * 2012-08-01 2015-07-30 Bgi-Shenzhen Biomarkers for diabetes and usages thereof

Also Published As

Publication number Publication date
CA2963013A1 (en) 2016-04-07
US10883146B2 (en) 2021-01-05
US20170226565A1 (en) 2017-08-10
EP3201317B1 (en) 2019-12-11
CN108064272A (zh) 2018-05-22
CN108064272B (zh) 2021-07-09
CN108064263B (zh) 2022-04-26
WO2016050110A1 (en) 2016-04-07
WO2016050111A1 (en) 2016-04-07
CN108064263A (zh) 2018-05-22
JP6485843B2 (ja) 2019-03-20
JP2017530708A (ja) 2017-10-19
KR101986442B1 (ko) 2019-06-05
RU2017115001A (ru) 2018-11-05
AU2015327511B2 (en) 2018-12-06
RU2691375C2 (ru) 2019-06-11
EP3201317A4 (en) 2017-08-09
AU2015327511A1 (en) 2017-04-20
CA2963013C (en) 2022-10-04
HK1248753A1 (zh) 2018-10-19
RU2017115001A3 (da) 2018-11-05
EP3201317A1 (en) 2017-08-09
HK1248764A1 (zh) 2018-10-19
KR20170063879A (ko) 2017-06-08

Similar Documents

Publication Publication Date Title
DK3229838T3 (da) Anti-C10orf54-antistoffer og anvendelser deraf
DK3126388T3 (da) Anti-EGFRvIII-antistoffer og anvendelser deraf
DK3215147T3 (da) Neurodæmpende norketamin-forbindelser og fremgangsmåder
DK3157552T3 (da) Syntac-polypeptider og anvendelser deraf
DK3302431T3 (da) Taxanpartikler og anvendelse deraf
DK3218358T3 (da) Ifluorometyl-aminopyridiner og difluorometyl-aminopyrimidiner
DK3227336T3 (da) Anti-CD79b-antistoffer og fremgangsmåder til anvendelse
DK3215601T3 (da) Fremgangsmåder til transduktion og celleforarbejdning
DK3237418T3 (da) Triazolopyrimidinforbindelser og anvendelser deraf
DK3149042T3 (da) PD-L1-antistoffer og anvendelser deraf
DK3725357T3 (da) Opholdsstrukturer og relaterede fremgangsmåder
DK3258951T3 (da) Anti-pvrig antistoffer og fremgangsmåder for anvendelse
DK3212255T3 (da) Selvorienterende sprøjte og sprøjtegrænseflade
DK3521289T3 (da) Mnk-inhibitorer og fremgangsmåder forbundet dermed
DK3928818T3 (da) Forstøver og beholder
DK3164774T3 (da) Fartøjshøjdebegrænsninger og styring
DK3126381T4 (da) Claudin-6-specifikke immunoreceptorer og t-celleepitoper
DK3193611T3 (da) Mk2-inhibitorer og anvendelser deraf
DK3116911T3 (da) Anti-mcam-antistoffer og tilhørende fremgangsmåder til anvendelse
DK3015526T3 (da) Hydrofluorolefinbaseret sammensætning og anvendelse deraf
DK3169703T3 (da) Kimær antigenreceptor og anvendelse deraf
DK3233221T3 (da) Træningsindretning
DK3209773T3 (da) Prolintolerante tripeptidylpeptidaser og anvendelser deraf
BR112016019548A2 (pt) Dispositivo de cálculo de auto-localização e metodo de cálculo de auto-localização
DK3161139T3 (da) Tlr-4-specifikke aptamerer og anvendelser heraf